AIM ImmunoTech Inc. is a company in the U.S. stock market and it is a holding in 4 U.S.-traded ETFs. AIM has around 500.9K shares in the U.S. ETF market. The largest ETF holder of AIM is the Vanguard Total Stock Market ETF (VTI), with approximately 291.09K shares.
We explain what’s driving the moves into this small corner of the market.
Dave Nadig answers readers' ETF questions in real time. Here’s the transcript.
Also, the case for dividend indexing.
Also, this ETF often outperforms in Q4.
Achieving DFA-style performance with ETFs.
With the Russell 2000 down almost 5 percent this year, is there a better way to skin the small-cap cat?
A money manager takes a good look at a ‘bad’ trade and talks about it openly.